Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Verrica Pharmaceuticals (VRCA) Receivables - Other (2022 - 2025)

Verrica Pharmaceuticals (VRCA) has 4 years of Receivables - Other data on record, last reported at $46000.0 in Q1 2025.

  • For Q1 2025, Receivables - Other fell 92.23% year-over-year to $46000.0; the TTM value through Mar 2025 reached $46000.0, down 92.23%, while the annual FY2024 figure was $29000.0, 82.74% down from the prior year.
  • Receivables - Other reached $46000.0 in Q1 2025 per VRCA's latest filing, up from $29000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $592000.0 in Q1 2024 and bottomed at $29000.0 in Q4 2024.
  • Average Receivables - Other over 4 years is $201769.2, with a median of $168000.0 recorded in 2023.
  • Peak YoY movement for Receivables - Other: surged 957.14% in 2024, then crashed 92.23% in 2025.
  • A 4-year view of Receivables - Other shows it stood at $99000.0 in 2022, then surged by 69.7% to $168000.0 in 2023, then tumbled by 82.74% to $29000.0 in 2024, then surged by 58.62% to $46000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Other were $46000.0 in Q1 2025, $29000.0 in Q4 2024, and $84000.0 in Q3 2024.